Qualitest Recalls Promethazine VC with Codeine Syrup Due to Impurity Issues
Qualitest Pharmaceuticals recalls specific lots of Promethazine VC with Codeine Syrup due to failed impurity specifications. Check lot numbers and expiration dates.
Recall notice
Failed Impurities/Degradation Specifications: A stability lot was out of specification for a known impurity at the 8 month Controlled Room Temperature stability time-point.
Contact the company
What happened, in plain English
Qualitest Pharmaceuticals is recalling Promethazine VC with Codeine Syrup because a stability lot was found to be out of specification for a known impurity. The recall affects specific lots manufactured for the company, distributed nationwide. The record does not specify what consumers should do with the product or provide a remedy. Read more at govinfonow.com/recall/44820-qualitest-pharmaceuticals-recalls-promethazine-vc-with-codeine-syrup-each-5.
Source Summary by GovInfoNow · govinfonow.com/recall/44820-qualitest-pharmaceuticals-recalls-promethazine-vc-with-codeine-syrup-each-5 · Updated October 12, 2026 · FDA enforcement record: FDA #D00432-2015
Cite this page
“Qualitest Recalls Promethazine VC with Codeine Syrup Due to Impurity Issues.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44820-qualitest-pharmaceuticals-recalls-promethazine-vc-with-codeine-syrup-each-5. Based on FDA recall #D00432-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D00432-2015%22&limit=1).
Why it’s dangerous
The product failed stability testing for a known impurity at the eight-month mark under controlled room temperature conditions. The specific health risks associated with this impurity level are not described in the provided record.
Who’s affected
Consumers who purchased Promethazine VC with Codeine Syrup from the affected lots between the manufacturing date and the recall announcement on March 25, 2015. Individuals using this prescription medication for cough or allergy relief are most likely to be affected.
How to tell if you have this one
Look for bottles labeled 'PROMETHAZINE VC WITH CODEINE SYRUP' manufactured by Qualitest Pharmaceuticals. Check the lot numbers and expiration dates: Lot L073D14A (Exp 07/31/15), Lot L073D14B (Exp 07/31/15), Lot 0000002247 (Exp 03/31/16), and Lot L063B14A (Exp 05/31/15). The product is available in 4 fl oz (NDC 0603-1588-54) and 16 fl oz (NDC 0603-1588-58) bottles.
- Brand
Qualitest Pharmaceuticals- Category
Drug
What to do — step by step
Check Your Lot Numbers
Verify if your bottle matches one of the recalled lot numbers: L073D14A, L073D14B, 0000002247, or L063B14A.
Contact Your Pharmacist
Since the remedy is not stated in the record, consult your healthcare provider or pharmacist for guidance on what to do with the medication.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 16 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D00432-2015 (March 25, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D00432-2015 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.